CORRECTION – VectivBio Announces Closing of $146.6 Million Initial Public Offering
April 13, 2021 21:53 ET | VectivBio AG
BASEL, Switzerland, April 13, 2021 (GLOBE NEWSWIRE) -- In a press release issued under the same headline earlier today by VectivBio Holding AG (Nasdaq: VECT), please note that in the first sentence...
VectivBio Announces Pricing of Initial Public Offering
April 08, 2021 22:27 ET | VectivBio AG
BASEL, Switzerland, April 08, 2021 (GLOBE NEWSWIRE) -- VectivBio Holding AG, (“Vectiv” or “VectivBio”) (Nasdaq: VECT), a clinical stage biopharmaceutical company focused on the discovery,...